1 year return (CAGR)
-46.52%
Oncolytics Biotech Inc Exchange (NASDAQ, USD)
ONCY
0.68
+0.00 (+0.40%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-31.25%
5 year return (CAGR)
-20.13%
10 year return (CAGR)
-12.96%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
86.61M
Price/Sales
-
Ent value
96.33M
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-11.67%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.68 |
| Daily high | 0.69 |
| Daily low | 0.64 |
| Daily Volume | 1.18M |
| All-time high | 82.46 |
| 1y analyst estimate | 4.25 |
| Beta | 1.15 |
| EPS (TTM) | -0.32 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 5 Mar 2026 |
Downside potential
Loading...
Downside potential data
| ONCY | S&P500 | |
| Current price drop from All-time high | -99.18% | -1.38% |
| Highest price drop | -99.60% | -56.47% |
| Date of highest drop | 5 Jun 2025 | 9 Mar 2009 |
| Avg drop from high | -78.93% | -10.68% |
| Avg time to new high | 782 days | 12 days |
| Max time to new high | 5652 days | 1805 days |
News
